Infection from fluoroquinolone-resistant extra-intestinal Escherichia coli is a global concern. In this study, isolation and characterization of fluoroquinolone-resistant extra-intestinal E. coli isolates obtained from hospital samples were undertaken to detect plasmid-mediated quinolone resistance (PMQR) genes.
The increasing trend of antibiotic resistance among bacterial pathogens is a cause of global concern 1 . Escherichia coli, a member of the family Enterobacteriaceae, is known to cause extraintestinal infections frequently showing resistance to fluoroquinolones nosocomial pneumonia, osteomyelitis and wound infections. Virulence factors, such as adhesins and exotoxins, play an important role in the pathogenesis of this microorganism 3 . Although the major reservoir of extra-intestinal pathogenic E. coli (ExPEC) causing infection remains the alimentary tract, other sources, such as contaminated food, are also incriminated 4 . ExPEC is known to harbour specialized virulence factors to cause extra-intestinal disease particularly UTI infections 5, 6 . Such isolates can pose a significant threat to public health since these can also harbour resistance determinants that can make a pathogen resistant to multiple antimicrobial classes including present generation cephalosporins and fluoroquinolones 7 .
Fluoroquinolones are an effective class of drugs used by clinicians for treating the infections of Gramnegative pathogens including UTI and hospitalacquired infections. However, the indiscriminate use of these antimicrobials has increased the prevalence of quinolone and fluoroquinolone resistance in bacterial pathogens usually mediated by point mutations in topoisomerase II (gyrA and gyrB) and topoisomerase IV (parC and parE) genes, as well as by the overexpression of efflux pumps 8 . In addition, plasmid-mediated quinolone resistance (PMQR) genes (qnrA, qnrB, qnrC, qnrS, qnrD, qnrE and qnrVC), associated with a modified aminoglycoside acetyltransferase gene [aac (6′)-1b-cr] and a specific quinolone efflux pump qepA and oqxAB have also been described in Enterobacteriaceae 2,9,10 . The PMQR genes in bacteria are known to display reduced susceptibility to fluoroquinolones; however, these may not present mutations in quinolone resistance determining region (QRDR) 11 .
Plasmid-mediated quinolone resistance mechanism is a cause of concern since PMQR genes are located on conjugative plasmids and have been shown to disseminate fluoroquinolone resistance in E. coli isolates. The pentapeptide protein complex encoded by qnr determinants are thought to bind to topoisomerase II preventing it from the action of fluoroquinolones, aac(6')-lb-cr is known to modify fluoroquinolones with piperazinyl moiety, while plasmid-mediated qepA encodes an efflux pump of major facilitator family 12 . 13 . Briefly, the bacterial isolates with the density of 0.5 McFarland turbidity were swabbed onto the pre-poured and dried Mueller Hinton agar (HiMedia Laboratories Pvt. Ltd., Mumbai). The antibiotic discs of ciprofloxacin (CIP) (5 μg) and nalidixic acid (NA) (30 μg) (HiMedia) were placed on the bacterial lawn using a sterile applicator. After overnight incubation at 37°C, inhibition zone diameters were measured and interpreted as resistant, sensitive or intermediate sensitive as per CLSI guidelines 13 . E. coli (ATCC 25922) was used as a quality control strain.
Material & Methods

Characterization of PMQR genes:
All the 43 isolates were checked for genus specific gene and for the presence of PMQR genes using PCR 14, 15 . PCR was performed in 30 µl reaction volumes containing 3 µl of 10 × buffer [100 mM Tris-HCl (pH 9), 1.5 mM MgCl 2 , 50 mM KCl and 1% gelatine], 100 µM of four deoxyribonucleotide triphosphates each (dATP, dGTP, dCTP and dTTP), 10 pmol of each forward and reverse primers and 1.0 U of Taq DNA polymerase with 2 µl of template DNA. All the isolates were tested for the presence of PMQR genes using primers listed in the Table I . The amplified PCR products were further purified using a QIAquick PCR purification Kit (Qiagen, Hilden, Germany).
Detection of mutation in QRDR using mismatch amplification mutation-MAMA-PCR:
A MAMA assay was performed on the 43 isolates to detect the point mutations in the QRDR 16 . The known point mutations at amino acid position 83 and 87 of gyrA, 80 and 84 of parC, 447 of gyrB and 416 amino acid position of parE were targeted 17 . The primers used in the study are outlined in Table I .
PCR was performed in 30 μl reaction volumes containing 3 μl of 10X Taq buffer, 83 μM of four deoxyribonucleotide triphosphates, 30, 20 and 10 picomoles of forward, MAMA reverse and control reverse primers, respectively and 1 U of Taq DNA polymerase with 2 μl of DNA as a template. PCR amplification was carried out in a thermal cycler (BioRad, USA) with the initial denaturation at 95°C for 5 min followed by 35 cycles of denaturation at 94°C, annealing at 55°C and extension at 72°C for 40 seconds respectively, and a final extension at 72°C for 10 min. PCR products were visualized on two per cent agarose gel stained with ethidium bromide (0.5 μg/ml) in 1× tris-acetate EDTA (TAE) buffer loaded with 10 μl of the reaction mixture and observed under UV light in a Gel Documentation system (Bio-Rad, USA).
DNA sequence analysis:
The purified PCR products were sequenced in an automated ABI 3100 Genetic analyser (Applied Biosystems, USA) using fluorescent label dye terminators. The nucleotide sequences were analyzed using BLAST programmes, blastn and blastp (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The amino acids deduced from the DNA sequences were obtained through a web-based programme Expasy Translate tool (https://web.expasy.org/translate/) following which the novel sequences were submitted to the GenBank.
Results
Forty-three extra-intestinal isolates of E. coli obtained from biological samples from patients with UTIs (21), wound infections (6), neonatal meningitis (5), septicaemia (5), nosocomial pneumonia (4) and osteomyelitis (2) from all age groups confirmed by phenotypic tests were reconfirmed as E. coli by PCRbased genotypic test for uidA gene.
Antibiogram analysis: Of the 43 quinolone/ fluoroquinolone-resistant isolates, 28 (65.11%) were found to be resistant to ciprofloxacin while 36 (83.72%) were resistant to nalidixic acid. Seven isolates were (Fig. 1A and B) . Seven (16.27%) isolates which were sensitive to both the antibiotics by phenotypic test, possessed plasmidmediated quinolone resistance genes, one of which was (qnrB) sequenced and submitted to the GenBank.
Detection of mutations in QRDR using MAMA-PCR:
The MAMA PCR in the absence of mutations(s) in sensitive isolates generated two PCR products from the wild-type gene using universal forward/ reverse and MAMA reverse primers whereas, a single amplicon was produced in resistant isolates with QRDR mutation(s) due to the inhibition of PCR in the presence of two or more mismatches at the 3'end of the MAMA primer ( Fig. 2A-D) . Nine (20.9%) of the 43 isolates resistant to both the antimicrobial agents harboured mutation only at amino acid position 83 of gyrA while one of the isolates possessed mutation (Table II ). An isolate resistant to nalidixic acid did not harbour any mutation in the QRDR. None of the isolates showed mutation in the gyrB and parE regions. The PCR products of gyrA and parC of one of the representative E. coli isolate were sequenced and analyzed. The partial sequences with possible QRDR mutations were submitted to the GenBank and were assigned GenBank accession numbers MF288967 for gyrA and MF2889868 for parC.
Discussion
Fluoroquinolones are a major class of antimicrobial drugs used widely for the treatment of infections caused by Gram-negative bacterial pathogens. E. coli being one of the major causes of several extra-intestinal and hospital-acquired infections is recognized as a major problem to tackle as it shows resistance to most of the quinolones and fluoroquinolones. Mechanisms underlying fluoroquinolone resistance were earlier thought to be confined to vertical inheritance due to the spontaneous occurrence of point mutations in QRDR regions 18 . However, now it is reported to be spread horizontally using plasmid-mediated qnr genes and efflux pump genes 19 . Although, in most of the cases, fluoroquinolone resistance is attributed to mutations in the QRDR regions, a reasonable percentage of isolates in this study also harboured PMQR genes and is in agreement with the reports of Kao et al 20 . Among the PMQR positive isolates the highest percentage harboured qnrS (77.77%) followed by qnrB (22.22%) and qnrA (11.11%); however, qepA was not observed in any of the isolates. In contrast, a study from China 21 showed presence of qnrS in isolates followed by qepA with the absence of qnrA and qnrB. Another study from China 22 showed the presence of qnr, aac(6′)-Ib-cr, qepA and oqxAB in 2.7, 24.5, 11.9 and 6.3 per cent, respectively of fluoroquinolone-resistant E. coli isolates. In a study from Korea, Yang et al 23 observed PMQR genes in 73.8 per cent of ciprofloxacin-resistant E. coli isolates. Although, in our study, the sample size was small, yet our results showed the presence of PMQR genes in 67.44 per cent of the E. coli isolates included. PMQRs, such as qepA and aac-(6′)-Ib, were found to be dominant in the aquatic environments 24 . This observation supported the notion that the aquatic environment might constitute the original source of PMQR genes 25 . Our study also demonstrated that extraintestinal E. coli isolates might carry silent antibiotic resistance genes, since a few fluoroquinolone sensitive isolates (16.27%) of E. coli harboured PMQRs such as qnrB and qnrS. Perhaps this gene did not express in these isolates as phenotypic resistance. The reason for the silent nature of the qnrS and qnrB of the sensitive isolates needs further study. Silencing of antibiotic resistance genes may be a phenomenon that has not received much attention. Enne et al 26 reported silencing of several plasmid-borne (pVE46) antibiotic resistance genes such as bla oxa-2 , aadA1, sul1 and tetA in E. coli isolated from pig following oral inoculation of organic piglets. There was no deletion of genes or promoter regions. However, the silent resistance genes were expressed again when the plasmid carrying resistance genes transferred to a new host. This suggested that the silencing phenomenon was due to the chromosomal effects of the host. Later, it was also found that the silencing was reversed at a low frequency of 10 −6 -10 −10 in the original host 26 . Deekshit et al 27 suggested that the deletion of promoter region was the main reason for unexpressive nature of the chloramphenicol acetyltransferase (catA) gene in Salmonella Weltevreden. These reports show the future risk associated with the global emergence of plasmid-borne resistance pattern of clinical pathogens and these PMQRs can also contribute to the elevated levels of ciprofloxacin minimum inhibitory concentrations (MICs) in clinical isolates.
All the fluoroquinolone-resistant isolates harbouring PMQR genes also had QRDR mutations. A MAMA-PCR was used to detect mutations at four major QRDRs (gyrA 83, gyrA 87, parC 80 and parC 84). It has been used to detect point mutations in gyrA and parC regions in fluoroquinolone-resistant bacterial pathogens [28] [29] [30] . The point mutation S83L at gyrA 83 was the most commonly observed change 31, 32 followed by mutation at gyrA 87. In the present study, 76.44 per cent (33/43) of the isolates harboured point mutation at gyrA 83 and 39.53 per cent (17/43) at gyrA 87. Thus, it is important to analyze these regions to check the multiple mutation status of resistant pathogens.
Among the 43 isolates of E. coli, seven different patterns of QRDR mutations were observed. Although, in the present study, all the mutations at gyrA 87 were associated with mutation at gyrA 83, one nalidixic acidresistant isolate (S5) harboured mutation only at gyrA position 87. Higher levels of quinolone/fluoroquinolone resistance with increased MICs in many bacterial pathogens are usually associated with double mutations in gyrA region 33 . Similarly, in our study, the isolates resistant to both the antibiotics harboured double mutation at gyrA and other regions. Some of the nalidixic acid-resistant isolates did not show any mutation in the QRDRs as reported by us earlier also 34 . Since PMQRs SHETTY et al: PLASMID MEDIATED QUINOLONE RESISTANCE 197 are mainly known to increase the MIC in resistant isolates, its exact relevance as a sole mechanism of fluoroquinolone resistance needs further study.
In conclusion, our study showed the occurrence of plasmid-mediated resistance as the second most encountered fluoroquinolone resistance mechanism among clinical isolates of E. coli. In addition, the detection of silent PMQR genes in sensitive isolates could pose a future risk of these isolates transforming into resistant forms upon antibiotic challenge. Hence, it is advisable to check for the presence of resistance determinants even in phenotypic sensitive isolates. 
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